To Study The Sahr (Insomnia) In Individual Of Different Temperament And Efficacy Of Raughan-e-kahu and Raughan-e-kaddu In It: A Comparative Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Reduction of symptoms in participants after 45 days of treatment within 3 follow-ups by given drugs
研究概览
简要总结
This open labelled clinical trials aims to assess the Efficacy Of Raughan-e-kahu and Raughan-e-kaddu In the management of Insomnia In Patients Of Different Temperament .
A total of 80 participants in which 2 groups: Group -A(40) and Group-B(40)
Having symptoms of Insomnia will be enrolled .
The participants will receive 4-6 ml of Raughan-e-kahu and Raughan-e-kaddu apply locally on scalp at night with duration of 45 days.
The primary objective is to evaluate the potential impact of Raughan-e-kahu and Raughan-e-kaddu on participants of different temperament and to know the incidence of disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient of both sex Patient age between 20 and 50 Patient who fullfill diagnostic criteria of Insomnia (Insomnia Severity Index Scale).
排除标准
- •Lesser than 20 and greater than 50 Known case of psychiatric disorders,anxiety,epilepsy,parasomnia,asthama,obstructive sleep apnea.
- •alcohol abuse .
- •pregnant and lactating women Patients of heart and kidney diseases veneral diseases history of trauma and head injury Patients having any malignancies.
结局指标
主要结局
Reduction of symptoms in participants after 45 days of treatment within 3 follow-ups by given drugs
时间窗: Reduction of symptoms in participants after 45 days of treatment within 3 follow-ups by given drugs
次要结局
- The Efficacy Of Two drugs participants overall well-being(The Incidence of any adverse effects during the course of treatment)